Respiratory Medicine
Volume 104, Issue 10 , Pages 1425-1435 , October 2010

Montelukast added to fluticasone propionate does not alter inflammation or outcomes

  • Ratko Djukanović

      Affiliations

    • University of Southampton, Southampton, UK
    • Corresponding Author InformationCorresponding author. Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom. Tel.: +44 2380 794195; fax: +44 2380 777996.
    • ,
  • Susan J. Wilson

      Affiliations

    • University of Southampton, Southampton, UK
    • ,
  • Wendy C. Moore

      Affiliations

    • Wake Forest University School of Medicine, Division of Pulmonary and Critical Care Medicine, Winston-Salem, NC, USA
    • ,
  • Steven M. Koenig

      Affiliations

    • Charlottesville, VA, USA
    • ,
  • Michel Laviolette

      Affiliations

    • Laval Hospital and University, Quebec, Canada
    • ,
  • Eugene R. Bleecker

      Affiliations

    • Wake Forest University School of Medicine, Division of Pulmonary and Critical Care Medicine, Winston-Salem, NC, USA
    • ,
  • W. Bruce Davis

      Affiliations

    • Medical College of Georgia, Augusta, GA, USA
    • ,
  • Dennis E. Doherty

      Affiliations

    • University of Kentucky, Lexington, KY, USA
    • ,
  • Ronald Olivenstein

      Affiliations

    • Meakins Christie Laboratories, McGill University; Montreal, Canada
    • ,
  • Elliott Israel

      Affiliations

    • Brigham and Women’s Hospital, Harvard Medical School; Boston, MA, USA
    • ,
  • Mani S. Kavuru

      Affiliations

    • East Carolina University, Brody School of Medicine, Division of Pulmonary and Critical Care Medicine; Greenville, NC, USA
    • ,
  • Eric Kleerup

      Affiliations

    • Pulmonary Medicine Associates Sleep Center, Reno, NV, USA
    • ,
  • Donna S. Reilly

      Affiliations

    • GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USA
    • ,
  • Steven W. Yancey

      Affiliations

    • GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USA
    • ,
  • Lisa D. Edwards

      Affiliations

    • GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USA
    • ,
  • John L. Stauffer

      Affiliations

    • CV Therapeutics, Palo Alto, CA, USA
    • ,
  • Paul M. Dorinsky

      Affiliations

    • Teva USA, Horsham, PA, USA
    • ,
  • Nizar N. Jarjour

      Affiliations

    • University of Wisconsin School of Medicine and Public Health, Section of Allergy, Pulmonary and Critical Care, Madison, WI, USA

Received 20 August 2009 ,Accepted 5 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(10)00157-5

doi: 10.1016/j.rmed.2010.04.004

Respiratory Medicine
Volume 104, Issue 10 , Pages 1425-1435 , October 2010

Article Tools

* Image Usage & Resolution